Allogeneic mesenchymal precursor cells in type 2 diabetes: A randomized, placebo-controlled, dose-escalation safety and tolerability pilot study

Jay S. Skyler, Vivian A. Fonseca, Karen R. Segal, Julio Rosenstock

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint Dive into the research topics of 'Allogeneic mesenchymal precursor cells in type 2 diabetes: A randomized, placebo-controlled, dose-escalation safety and tolerability pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences